Frances K. Heller

SVP, Business Development, Bristol-Myers Squibb.

Companies

Monterey Innovation Acquisition CorpBoard member Sep 30, 2021 to Sep 30, 2021¹
Zafgen (United States)Board member Sep 18, 2014 to Oct 17, 2017²
Bristol-Myers SquibbSVP, Business Development Oct 3, 2012 to Mar 12, 2014³
ExelixisEVP, Business Development Aug 5, 2008 to May 17, 2011⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Bristol-Myers Squibb BMY4,218 shares⁵$257.1K at $60.95Mar 12, 2014

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 10, 2014Shares withheld for tax 958 shares at $56.14 of Bristol-Myers Squibb⁵
Mar 10, 2014Other 730 shares of Bristol-Myers Squibb⁵
Mar 10, 2014Exercised options 1,609 shares of Bristol-Myers Squibb⁵
Oct 1, 2013Shares withheld for tax 1,658 shares at $47.24 of Bristol-Myers Squibb⁶
Oct 1, 2013Exercised options 4,451 shares of Bristol-Myers Squibb⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMonterey Innovation Acquisition Corp, Board member
2
SEC EDGARZafgen (United States), Board member
3
SEC EDGARBristol-Myers Squibb, SVP, Business Development
4
SEC EDGARExelixis, EVP, Business Development
5
SEC EDGARBristol-Myers Squibb shares after the filing of Mar 12, 2014
6
SEC EDGARForm 4 filed Oct 2, 2013